# Regulatory Compliance Documentation for Medical Data Handling

This document establishes a formal compliance framework for handling medical data in oncology research, ensuring adherence to HIPAA regulations, data protection standards, and best practices for PHI management.

## 1. HIPAA Compliance Framework

### Overview
The Health Insurance Portability and Accountability Act (HIPAA) establishes national standards for protecting individually identifiable health information. For oncology research involving Protected Health Information (PHI), compliance requires implementing administrative, physical, and technical safeguards.

### Key HIPAA Components for Research
- **Privacy Rule (45 CFR Part 160 and Subparts A and E of Part 164)**: Regulates use and disclosure of PHI for research purposes
- **Security Rule (45 CFR Part 164, Subparts A and C of Part 164)**: Protects electronic PHI (ePHI) through administrative, physical, and technical safeguards
- **Breach Notification Rule (45 CFR Part 164, Subparts A and D of Part 164)**: Requires notification following impermissible disclosures of unsecured PHI

### Covered Entity Status
As a research institution handling PHI for oncology studies, Ferrumyx operates as a covered entity under HIPAA when:
- Providing healthcare services
- Conducting research involving PHI
- Maintaining health information for research purposes

### Research-Specific Considerations
- **Individual Authorization**: Obtain written authorization for PHI use/disclosure in research
- **Waiver of Authorization**: IRB may waive authorization if research cannot practicably be conducted without PHI and waiver will not adversely affect privacy rights
- **Limited Data Sets**: Use de-identified data with limited identifiers under Data Use Agreement (DUA)
- **De-identification**: Remove 18 identifiers to create de-identified data not subject to HIPAA

## 2. PHI Handling

### PHI Classification and Protection

#### Definition
Protected Health Information (PHI) is any individually identifiable health information, including demographic data, transmitted or maintained in any form (electronic, paper, oral).

#### Data Sensitivity Levels
- **High Sensitivity**: Genomic data, biopsy results, treatment history
- **Medium Sensitivity**: Diagnostic imaging, lab results, medication records
- **Low Sensitivity**: Demographic data, appointment schedules

#### Handling Procedures
- **Collection**: Obtain IRB-approved consent/authorizations
- **Storage**: Encrypt ePHI at rest and in transit
- **Transmission**: Use secure channels (SFTP, HTTPS, VPN)
- **Processing**: Implement access controls and audit logging
- **Retention**: Follow minimum retention periods (6 years for HIPAA)
- **Destruction**: Secure deletion methods compliant with NIST guidelines

#### De-identification Standards
Follow Safe Harbor method (45 CFR 164.514(b)(2)):
- Remove 18 direct identifiers
- Statistical verification that risk of re-identification < 0.04%

### Data Classification Matrix

| Data Type | Sensitivity | Encryption Required | Access Level |
|-----------|-------------|-------------------|--------------|
| Genomic sequences | Critical | AES-256-GCM | Researcher + IRB |
| Patient identifiers | High | AES-256 | Researcher + Consent |
| Study metadata | Medium | AES-128 | Team members |
| Public datasets | Low | None | Open access |

## 3. Audit Trails

### Comprehensive Logging Requirements

#### Audit Control Standard (45 CFR 164.312(b))
Implement hardware/software mechanisms to record and examine activity in systems containing ePHI.

#### Required Audit Events
- **User Authentication**: Successful/failed login attempts, session timeouts
- **Data Access**: View, create, modify, delete operations on PHI
- **Data Exports**: Bulk downloads, API calls, print operations
- **Administrative Actions**: Role changes, permission modifications
- **Security Events**: Failed access attempts, anomaly detections

#### Log Content Requirements
- User ID/username
- Date/time of access
- Affected data/record identifiers
- Action performed (view, edit, delete, export)
- Success/failure status
- IP address/device information
- Application/system accessed

#### Audit Trail Implementation
- **Application Logs**: Monitor user activities in research databases
- **System Logs**: Capture authentication and system-level events
- **User Logs**: Track individual researcher actions
- **Retention**: 6 years minimum from date of creation
- **Protection**: Immutable storage, tamper-proof, access controls

#### Regular Review Procedures
- **Daily Monitoring**: Automated alerts for suspicious activities
- **Weekly Reviews**: Sample audit log analysis
- **Monthly Reports**: Compliance verification and trend analysis
- **Annual Audits**: Comprehensive review by independent auditor

## 4. Data Retention

### Retention Policies for Medical Research Data

#### HIPAA Requirements (45 CFR 164.316(b)(2)(i))
- Retain audit logs for 6 years from creation date
- Retain authorizations and accounting disclosures for 6 years
- Retain breach documentation for 6 years

#### Research-Specific Retention
- **Essential Research Records**: Minimum 3 years post-study completion (OHRP)
- **Clinical Trial Data**: 2 years after last approval of marketing application or discontinuation
- **Genomic Data**: Indefinite retention for longitudinal studies
- **Consent Forms**: Until study completion + 6 years (HIPAA)

#### Retention Schedule Matrix

| Data Type | Minimum Retention | Maximum Retention | Destruction Method |
|-----------|------------------|------------------|-------------------|
| Raw genomic data | Study duration + 7 years | Indefinite | Secure erase |
| Processed results | Study completion + 3 years | 10 years | Cryptographic erasure |
| Audit logs | 6 years | 10 years | NIST-compliant wipe |
| Consent forms | Study completion + 6 years | 10 years | Shredding/incineration |
| IRB records | 3 years post-study | 7 years | Secure disposal |

#### Data Destruction Procedures
- **Secure Deletion**: Use DoD 5220.22-M or NIST SP 800-88 methods
- **Physical Destruction**: Shredding, degaussing, incineration for paper/media
- **Verification**: Document destruction with certificates
- **Chain of Custody**: Maintain records of destruction process

## 5. Access Controls

### Role-Based Access and Data Sensitivity Levels

#### Access Control Principles
- **Minimum Necessary**: Provide access only to PHI required for research purpose
- **Role-Based Access Control (RBAC)**: Permissions based on job function
- **Need-to-Know**: Access limited to specific datasets required for work

#### User Roles and Permissions

| Role | PHI Access Level | Permissions | Approval Required |
|------|------------------|-------------|------------------|
| Principal Investigator | Full study data | Create, read, update, delete | IRB approval |
| Research Coordinator | Assigned patient data | Read, update | PI supervision |
| Data Analyst | De-identified datasets | Read, analyze | DUA + IRB |
| IT Administrator | System access | Technical maintenance | Security officer |
| IRB Member | Protocol review | Limited PHI access | IRB authorization |

#### Technical Controls
- **Authentication**: Multi-factor authentication for all PHI access
- **Authorization**: Automated permission enforcement
- **Encryption**: Data-at-rest and in-transit encryption (AES-256-GCM for secrets)
- **Network Security**: VPN access, firewall rules, intrusion detection
- **WASM Sandboxing**: Isolated execution environment for bioinformatics tools with resource limits and capability-based permissions

#### WASM Sandboxing for PHI Protection
- **Execution Isolation**: Bioinformatic tools run in WebAssembly sandbox with no direct filesystem or network access
- **Resource Limits**: CPU time, memory usage, and execution timeouts enforced per tool invocation
- **Capability-Based Security**: Tools granted minimal permissions required for their function
- **Audit Logging**: All tool executions logged with PHI access tracking
- **Leak Detection**: Automated monitoring for potential data exfiltration attempts

#### Access Review Procedures
- **Annual Reviews**: Verify continued need for access
- **Termination Procedures**: Immediate revocation upon role change/departure
- **Emergency Access**: Break-glass procedures with audit logging
- **Monitoring**: Real-time access monitoring and alerting

## 6. Incident Response

### Breach Notification and Incident Response Procedures

#### Incident Response Plan Requirements (45 CFR 164.308(a)(6))
Maintain policies and procedures to address security incidents involving ePHI.

#### Breach Definition
Impermissible use/disclosure of PHI compromising security/privacy, unless low probability of compromise after risk assessment.

#### Risk Assessment Factors (45 CFR 164.402)
- Nature/extent of PHI involved
- Unauthorized recipient's identity
- Whether PHI was acquired/viewed
- Risk mitigation extent

#### Notification Timelines
- **Individual Notification**: Without unreasonable delay, no later than 60 days
- **HHS Notification**: Within 60 days for breaches affecting ≥500 individuals
- **Media Notification**: Within 60 days for breaches affecting ≥500 individuals

#### Incident Response Procedures

##### Phase 1: Detection and Assessment
1. Incident detection via monitoring/alerts
2. Initial triage and containment
3. Breach risk assessment
4. Documentation of findings

##### Phase 2: Containment and Recovery
1. Isolate affected systems
2. Preserve evidence
3. Notify affected individuals
4. Implement corrective actions

##### Phase 3: Notification and Reporting
1. Notify HHS if applicable
2. Notify media if applicable
3. Update incident response plan
4. Conduct post-incident review

#### Breach Response Team
- **Incident Commander**: Overall coordination
- **Privacy Officer**: Privacy/compliance oversight
- **Security Officer**: Technical response
- **Legal Counsel**: Regulatory guidance
- **Communications**: Stakeholder notifications

## 7. Compliance Testing

### Procedures for Compliance Verification

#### Regular Testing Requirements
- **Risk Analysis**: Annual comprehensive assessment (45 CFR 164.308(a)(1)(ii)(A))
- **Penetration Testing**: Annual external testing
- **Vulnerability Scanning**: Monthly automated scans
- **Access Control Testing**: Quarterly permission reviews

#### Compliance Audit Procedures
- **Internal Audits**: Quarterly self-assessments
- **External Audits**: Annual third-party HIPAA audit
- **IRB Compliance Reviews**: Protocol-specific audits
- **System Audits**: Pre-production and post-deployment

#### Testing Framework
- **Unit Testing**: Individual control validation
- **Integration Testing**: System-wide compliance verification
- **User Acceptance Testing**: Researcher workflow compliance
- **Penetration Testing**: Security control effectiveness

#### Audit Checklist
- [ ] PHI classification and handling procedures
- [ ] Access control implementation
- [ ] Audit logging functionality
- [ ] Data retention compliance
- [ ] Incident response plan testing
- [ ] Staff training completion
- [ ] Vendor compliance verification

#### Remediation Procedures
- **Issue Identification**: Automated monitoring and manual reviews
- **Risk Prioritization**: Critical, high, medium, low impact
- **Corrective Actions**: Timeline-based remediation plans
- **Verification**: Post-remediation testing and validation
- **Documentation**: Audit trail of all compliance activities

### Training and Awareness
- **Initial Training**: HIPAA compliance for all personnel
- **Annual Refresher**: Updates on policies and procedures
- **Role-Specific Training**: Specialized training for data handlers
- **Incident Response Drills**: Quarterly tabletop exercises

This framework establishes the foundation for HIPAA-compliant medical data handling in oncology research. Regular review and updates ensure ongoing compliance with evolving regulations and best practices.</content>
<parameter name="filePath">D:\AI\Ferrumyx\docs\COMPLIANCE.md